Galapagos NV
GLPG
#4542
Rank
ยฃ1.58 B
Marketcap
ยฃ24.02
Share price
-1.60%
Change (1 day)
19.73%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: ยฃ1.58 Billion

As of March 2026 Galapagos NV has a market cap of ยฃ1.58 Billion. This makes Galapagos NV the world's 4542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.58 B-1.87%
2025ยฃ1.61 B12.74%
2024ยฃ1.43 B-31.82%
2023ยฃ2.10 B-12.94%
2022ยฃ2.41 B-10.76%
2021ยฃ2.70 B-43.03%
2020ยฃ4.75 B-53.89%
2019ยฃ10.30 B160.55%
2018ยฃ3.95 B11.27%
2017ยฃ3.55 B47.14%
2016ยฃ2.41 B45.19%
2015ยฃ1.66 B353.78%
2014ยฃ0.36 B-3.53%
2013ยฃ0.37 B8.67%
2012ยฃ0.34 B52.36%
2011ยฃ0.22 B-16.73%
2010ยฃ0.27 B74.96%
2009ยฃ0.15 B124.65%
2008ยฃ70.11 M

End of Day market cap according to different sources

On Mar 19th, 2026 the market cap of Galapagos NV was reported to be:

ยฃ1.60 Billion
by Nasdaq info icon info icon
ยฃ1.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ425.58 B 26,735.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ137.49 B 8,570.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ272.06 B 17,054.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ81.49 B 5,038.89%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ211.81 B 13,255.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ213.56 B 13,366.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ78.12 B 4,825.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
ยฃ69.63 M-95.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ25.10 B 1,483.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel